Money Moves: These 8 Philly-Area Companies Raised More Than $118M Total This Spring

A handful of Philly-area companies across industries like biosciences and and information sciences have announced some fundraising in the past two months ranging from a few hundred thousands dollars up to $45 million.

In late May, Palvella Therapeutics, a Wayne-based biopharmaceutical company focused on genetic diseases, announced that it had raised $45 million in Series C funding. In addition, the company said that two key investors — Scott Morenstein, managing director of CAM Capital, and Cory Freedland, principal of Samsara BioCapital — have been nominated to join the Palvella board of directors.

“Palvella was founded on fundamental beliefs that every individual with a rare disease deserves a treatment and that significant value creation occurs upon the introduction of the first approved therapy or a serious rare genetic disease,” said Wes Kaupinen, president and CEO.

The capital will support the advancement of PTX-022, its gel for the treatment of adults with pachyonychia congenita, a rare, chronically debilitating and lifelong skin disease.

Early last month, medical transportation startup Roundtrip received a $252,000 Small Business Innovation Research grant to conduct a study focused on patients with opioid use disorder along with the University of Pennsylvania, Lyft and Contra Costa Health Services in California, Philadelphia Business Journal reported.

Read the full article here.

Previous

Next